Clinical trial

Identifying Prognostic Variables for Persistent UL Dysfunctions After Breast Cancer Treatment -Reliability and Validity

NCT05371847

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-04-26

PhaseNA

Study timeline

Study start (actual)2022-04-26Date precision: day

Registry last updated2024-05-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

assessment for upper limb dysfunctionOTHER

retest assessmentOTHER

Sponsors & collaborators

KU Leuvenlead sponsor

Universitaire Ziekenhuizen KU Leuvencollaborator

Vrije Universiteit Brusselcollaborator

Mapped research locations

LeuvenBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05371847 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.